Algeta, the Glossary
Algeta ASA was founded in 1997 by Roy H. Larsen and Øyvind S. Bruland in Oslo, Norway as a private biotechnology and pharmaceutical company.[1]
Table of Contents
21 relations: Alpha particle, Bayer, Biotechnology, Bloomberg News, Bone metastasis, Calcium, Clinical trial, European Medicines Agency, Food and Drug Administration, HealthCap, Hydroxyapatite, Mergers and acquisitions, Norway, Oslo, Oslo Stock Exchange, Pharmaceutical industry, Prostate cancer, Radiopharmaceutical, Radium-223, Saline (medicine), Survival rate.
- Biotechnology companies established in 1997
- Biotechnology companies of Norway
- Pharmaceutical companies established in 1997
- Pharmaceutical companies of Norway
Alpha particle
Alpha particles, also called alpha rays or alpha radiation, consist of two protons and two neutrons bound together into a particle identical to a helium-4 nucleus.
Bayer
Bayer AG (English:, commonly pronounced) is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world.
See Algeta and Bayer
Biotechnology
Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services.
Bloomberg News
Bloomberg News (originally Bloomberg Business News) is an international news agency headquartered in New York City and a division of Bloomberg L.P. Content produced by Bloomberg News is disseminated through Bloomberg Terminals, Bloomberg Television, Bloomberg Radio, Bloomberg Businessweek, Bloomberg Markets, Bloomberg.com, and Bloomberg's mobile platforms.
Bone metastasis, or osseous metastatic disease, is a category of cancer metastases that result from primary tumor invasions into bones.
See Algeta and Bone metastasis
Calcium
Calcium is a chemical element; it has symbol Ca and atomic number 20.
Clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison.
European Medicines Agency
The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.
See Algeta and European Medicines Agency
Food and Drug Administration
The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.
See Algeta and Food and Drug Administration
HealthCap
HealthCap is a specialized provider of venture capital within life sciences.
Hydroxyapatite
Hydroxyapatite (IMA name: hydroxylapatite) (Hap, HAp, or HA) is a naturally occurring mineral form of calcium apatite with the formula, often written to denote that the crystal unit cell comprises two entities.
Mergers and acquisitions
Mergers and acquisitions (M&A) are business transactions in which the ownership of companies, business organizations, or their operating units are transferred to or consolidated with another company or business organization.
See Algeta and Mergers and acquisitions
Norway
Norway (Norge, Noreg), formally the Kingdom of Norway, is a Nordic country in Northern Europe, situated on the Scandinavian Peninsula.
Oslo
Oslo (or; Oslove) is the capital and most populous city of Norway.
See Algeta and Oslo
Oslo Stock Exchange
Oslo Stock Exchange (Oslo Børs) (OSE: OSLO) is a stock exchange within the Nordic countries and offers Norway's only regulated markets for securities trading today. The stock exchange offers a full product range including equities, derivatives and fixed income instruments. The Euronext consortium of European stock exchanges controls Oslo Stock Exchange as of June 2019.
See Algeta and Oslo Stock Exchange
Pharmaceutical industry
The pharmaceutical industry is an industry involved in medicine that discovers, develops, produces, and markets pharmaceutical goods for use as drugs that function by being administered to (or self-administered by) patients using such medications with the goal of curing and/or preventing disease (as well as possibly alleviating symptoms of illness and/or injury).
See Algeta and Pharmaceutical industry
Prostate cancer
Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder.
See Algeta and Prostate cancer
Radiopharmaceutical
Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes.
See Algeta and Radiopharmaceutical
Radium-223
Radium-223 (223Ra, Ra-223) is an isotope of radium with an 11.4-day half-life.
Saline (medicine)
Saline (also known as saline solution) is a mixture of sodium chloride (salt) and water.
See Algeta and Saline (medicine)
Survival rate
Survival rate is a part of survival analysis.
See also
Biotechnology companies established in 1997
- Algeta
- Arena Pharmaceuticals
- Benitec Biopharma
- BioMarin Pharmaceutical
- Biolex
- Cagemax
- GPC Biotech
- Labcorp Drug Development
- Macrogen
- Mendel Biotechnology
- ReNeuron
- Seagen
- TME Pharma
- Vernalis Research
Biotechnology companies of Norway
Pharmaceutical companies established in 1997
- Actelion
- Algeta
- Arena Pharmaceuticals
- Benitec Biopharma
- BioMarin Pharmaceutical
- Boehringer Ingelheim Animal Health
- Cytokinetics
- Dechra Pharmaceuticals
- Endo International
- GTx Incorporated
- Jiangsu Hengrui
- Labcorp Drug Development
- Seagen
- TME Pharma
- Targanta Therapeutics Corporation
- Vectura
Pharmaceutical companies of Norway
- Algeta
- Hafslund Nycomed
- Nycomed
- Photocure
- Weifa
References
[1] https://en.wikipedia.org/wiki/Algeta
Also known as Algeta ASA.